Cronos Group Inc. (TSE:CRON – Get Free Report) passed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of C$4.64 and traded as high as C$4.75. Cronos Group shares last traded at C$4.70, with a volume of 216,168 shares traded.
Analyst Upgrades and Downgrades
Separately, TD boosted their price target on Cronos Group from C$5.50 to C$6.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Three investment analysts have rated the stock with a Buy rating. According to MarketBeat, Cronos Group presently has an average rating of “Buy” and a consensus price target of C$4.92.
Get Our Latest Stock Report on CRON
Cronos Group Stock Up 1.7%
The firm’s fifty day moving average price is C$4.64 and its 200-day moving average price is C$3.98. The company has a debt-to-equity ratio of 0.12, a current ratio of 16.18 and a quick ratio of 24.01. The company has a market capitalization of C$1.73 billion, a price-to-earnings ratio of 24.74, a P/E/G ratio of 0.12 and a beta of 1.29.
Cronos Group (TSE:CRON – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported C$0.13 EPS for the quarter. Cronos Group had a net margin of 38.95% and a return on equity of 6.46%. The business had revenue of C$75.31 million for the quarter. Sell-side analysts expect that Cronos Group Inc. will post -0.26 earnings per share for the current fiscal year.
Cronos Group Company Profile
Cronos is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT and Lord Jones. For more information about Cronos and its brands, please visit: thecronosgroup.com.
Read More
- Five stocks we like better than Cronos Group
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.
